Publication | Open Access
Targeting MS4A4A on tumour-associated macrophages restores CD8+ T-cell-mediated antitumour immunity
107
Citations
34
References
2023
Year
Targeting MS4A4A could enhance the ICI efficacy and represent a new anticancer immunotherapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1